This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2011 Mar;28(3):490-3.

doi: 10.1007/s11095-010-0293-5. Epub 2010 Oct 1.

The unique potential for noninvasive imaging in modernizing drug development and in transforming therapeutics: PET/MRI/MRS

Affiliations

PMID: 20886263
DOI: 10.1007/s11095-010-0293-5

Review

The unique potential for noninvasive imaging in modernizing drug development and in transforming therapeutics: PET/MRI/MRS

Walter Wolf. Pharm Res. 2011 Mar.

. 2011 Mar;28(3):490-3.

doi: 10.1007/s11095-010-0293-5. Epub 2010 Oct 1.

Author

Affiliation

¹ Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, California, USA. wwolfw@usc.edu

PMID: 20886263
DOI: 10.1007/s11095-010-0293-5

No abstract available

PubMed Disclaimer

Similar articles

[New trends and novel possibilities in the management of oncologic patients: clinical uses of PET/MRI].
Borbély K. Borbély K. Magy Onkol. 2015 Mar;59(1):10-6. Epub 2014 Sep 28. Magy Onkol. 2015. PMID: 25763908 Review. Hungarian.
The FDA and radiologists: momentum for change.
Hillman BJ. Hillman BJ. J Am Coll Radiol. 2005 Jun;2(6):459-60. doi: 10.1016/j.jacr.2005.02.015. J Am Coll Radiol. 2005. PMID: 17411858 No abstract available.
Advanced MR imaging and ¹⁸F-DOPA PET characteristics of H3K27M-mutant and wild-type pediatric diffuse midline gliomas.
Piccardo A, Tortora D, Mascelli S, Severino M, Piatelli G, Consales A, Pescetto M, Biassoni V, Schiavello E, Massollo M, Verrico A, Milanaccio C, Garrè ML, Rossi A, Morana G. Piccardo A, et al. Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1685-1694. doi: 10.1007/s00259-019-04333-4. Epub 2019 Apr 27. Eur J Nucl Med Mol Imaging. 2019. PMID: 31030232
[Positron emission tomography/magnetic resonance: Present and future].
Kohan AA, Vercher Conejero JL, Gaeta MC, Pelegrí Martinez L, Ros PR. Kohan AA, et al. Rev Esp Med Nucl Imagen Mol. 2013 May-Jun;32(3):167-76. doi: 10.1016/j.remn.2013.01.004. Epub 2013 Apr 11. Rev Esp Med Nucl Imagen Mol. 2013. PMID: 23582491 Review. Spanish.
Cardiac Positron Emission Tomography-Magnetic Resonance Imaging: Current Status and Future Directions.
Lau JMC, Raptis DA, Laforest R, Nensa F, Zheng J, Gropler RJ, Woodard PK. Lau JMC, et al. J Thorac Imaging. 2018 May;33(3):139-146. doi: 10.1097/RTI.0000000000000327. J Thorac Imaging. 2018. PMID: 29489584 Review.

See all similar articles

Cited by

Endogenous fluorophores enable two-photon imaging of the primate eye.
Palczewska G, Golczak M, Williams DR, Hunter JJ, Palczewski K. Palczewska G, et al. Invest Ophthalmol Vis Sci. 2014 Jun 26;55(7):4438-47. doi: 10.1167/iovs.14-14395. Invest Ophthalmol Vis Sci. 2014. PMID: 24970255 Free PMC article.
Current opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo.
Lin G, Chung YL. Lin G, et al. Biomed Res Int. 2014;2014:625095. doi: 10.1155/2014/625095. Epub 2014 Mar 3. Biomed Res Int. 2014. PMID: 24724090 Free PMC article. Review.

References

1. J Clin Oncol. 1988 Oct;6(10):1653-64 - PubMed
1. Cancer Res. 1977 Jul;37(7 Pt 1):2306-8 - PubMed
1. Proc Natl Acad Sci U S A. 1990 Jan;87(1):492-6 - PubMed
1. Nuklearmedizin. 1982 Feb;21(1):1-7 - PubMed
1. Adv Drug Deliv Rev. 2000 Mar 15;41(1):55-74 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Medical
- MedlinePlus Health Information